🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

11 recruiting trials

for Chronic Inducible Urticaria

Deep Phenotyping of CIndU NCT07359430n/a3 sites📍 Leiden📍 Rotterdam📍 Utrecht Centre for Human Drug Research, Netherlands Repeat PET/CT Imaging in People With CAPS and Anakinra-Induced Amyloidosis Using an Amyloid-Reactive Peptide to Measure Changes in Organ-Specific Amyloid Load NCT06974877Phase 11 site📍 Bethesda National Institute of Allergy and Infectious Diseases (NIAI… · Tests: 124I AT-01 A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single and Multiple Doses of EDP-978 in Healthy Adults NCT07540910Phase 11 site📍 San Antonio Enanta Pharmaceuticals, Inc · Tests: EDP-978, Placebo Ilaris NIS in Korea NCT06838143n/a1 site📍 Seoul Novartis Pharmaceuticals · Tests: Ilaris Study of Remibrutinib (LOU064) Efficacy and Safety and Exploration of Its Mechanism of Action in Participants With Chronic Urticaria NCT06865651Phase 217 sites📍 North Miami Beach📍 Glenview📍 Grenoble Novartis Pharmaceuticals · Tests: Remibrutinib, Placebo A Study to Investigate Efficacy, Safety and Tolerability of Barzolvolimab Versus Placebo in Adults With Cold Induced Urticaria and Symptomatic Dermographism Inadequately Controlled by H1-antihistamines (EMBARQ - ColdU and SD) NCT07266402Phase 372 sites📍 Birmingham📍 Scottsdale📍 Bakersfield Celldex Therapeutics · Tests: Barzolvolimab, Matching Placebo Characteristics and Management of Patients With Severe Chronic Spontaneous and/or Inducible Urticaria Refractory to Optimized Omalizumab Treatment: A French Multicenter Observational Study. NCT07833696n/a1 site📍 Besançon Centre Hospitalier Universitaire de Besancon · Tests: drug effect Natural History, Pathogenesis, and Outcome of Autoinflammatory Diseases (NOMID/CAPS, DIRA, CANDLE, SAVI, NLRC4-MAS, Still'S-like Diseases, and Other Undifferentiated Autoinflammatory Diseases) NCT02974595n/a1 site📍 Bethesda National Institute of Allergy and Infectious Diseases (NIAI… Analysis of the Role of IgE Proteoforms in Health and Disease NCT07328178n/a1 site📍 Leuven KU Leuven · Tests: Blood sample collection Circadian Rhythm Deregulation in Patients With CAPS NCT06544018NA6 sites📍 Bron📍 Lille📍 Lyon Hospices Civils de Lyon · Tests: Genetic analysis of NLRP3, Circadian rhythm measurement, Saliva sampling, Questionnaire, AIDAI score A Phase 1 Study of GTX-B001 in Healthy Subjects and Patients With Chronic Inducible Urticaria NCT07181369Phase 13 sites📍 Berlin📍 Berlin📍 Halle Granular Therapeutics Limited · Tests: GTX-B001, Normal Saline
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy